Latest Statistics and Forecasts Regarding the Sleep Disorders Market: Insomnia, Sleep Apnea, Restless Leg Syndrome, Bruxism, Narcolepsy and Sleepwalking

Business Wire, March 03, 2009

Figure 2.29: RLS Sufferers Referred to Specialists by Country 64

Figure 3.1: Dalmane's Market, 2005-2007 71

Figure 3.2: Global Market for Lunesta, 2005-2007 74

Figure 3.3: Sonata's (Zaleplon) Sales, 2005-2007 75

Figure 3.4: Total Sales for Four Leading Brands of Sleeping Pills, 2007 76

Figure 3.5: WASO 84

Figure 5.1: Number of Accredited Sleep Labs in the U.S., 2003-2007 105

Figure 5.2: Sleep Monitoring Revenue Distribution by Provider Type in the U.S.,2006 106

Figure 5.3: U.S. Sleep Lab Revenues, 2003-2007 106

Figure 6.1: Chad's Business for the Six Months Ended September, 2007 and 2006 111

Figure 6.2: Chad's Research and Development Expenditure for Six Months Ended September, 2007 and 2006 111

Figure 6.3: Chad's Business in Geographic Region/Country for Six Months Ended September, 2007 112

Figure 6.4: Compumedics' Revenue, 2003-2008 113

Figure 6.5: Compumedics' Research and Development (R&D) Expenditure, 2007-2008 113

Figure 6.6: Compumedics' Business Revenue from the U.S., 2003-2008 114

Figure 6.7: Compumedics' Global Sleep Diagnostic Market, 2008 114

Figure 6.8: Compumedics' Global Brain Research Market, 2008 115

Figure 6.9: Compumedics' Global Neurodiagnostics Market, 2008 115

Figure 6.10: Compumedics' Global Neuromedical Supplies Market, 2008 116

Figure 6.11: Compumedics' Global Doppler Ultrasound Market, 2008 116

Figure 6.12: Covidien's Medical Device Business Sales, 2005-2007 123

Figure 6.13: Covidien's Pharmaceutical Products Business Sales, 2005-2007 123

Figure 6.14: Covidien's Imaging Solutions Business Sales, 2005-2007 124

Figure 6.15: Covidien's Medical Supplies Business Sales, 2005-2007 124

Figure 6.16: Covidien's Retail Products Business Sales, 2005-2007 125

Figure 6.17: Covidien's Net Sales by Geographic Area, 2007 125

Figure 6.18: Covidien's Research and Development Expenditure, 2005-2007 126

Figure 6.19: ResMed's Percent Net Revenue from North and Latin America, 2006-2008 136

Figure 6.20: ResMed's Percent Net Revenue from Europe, 2006-2008 137

Figure 6.21: ResMed's Percent Net Revenue from Asia Pacific, 2006-2008 137

Figure 6.22: Number of Employees in ResMed and its Subsidiaries, 2008 138

Figure 6.23: ResMed's Consolidated Statement of Income Data, 2004-2008 138

Figure 6.24: ResMed's Research and Development Expenditure, 2004-2008 139

Figure 6.25: Respironics' Business, 2006-2007 145

Figure 6.26: SomnoMed's OSA Global Market Size Projection, 2007-2018 155

Figure 6.27: Growth Projection for Somnomed MAS, 2005-2010 156

Figure 6.28: Acadia's Revenue, 2003-2007 159

Figure 6.29: Acadia's Research and Development Expenses, 2003-2007 159

Figure 6.30: Actelion's Sales Revenue from Three of its Brands, 2007 161

Figure 6.31: Actelion's Revenue, 2007-2008 161

Figure 6.32: Actelion's Net Revenues and Net Income, 2006-2007 162

Figure 6.33: Actelion's Sales Revenue, 2006-2008 162

Figure 6.34: Arena's Research Expenditure, 2005-2007 168

Figure 6.35: Arrena's Revenue, 2003-2007 169

Figure 6.36: Arena's Revenue from Partnered Programs, 2005-2007 169